Welcome to
HabPharmaceuticals
LOADING
Our Team
Chairman and Managing Director
Mr. Krishnakumar Agarwal is the Chairman and Managing Director of HAB Pharmaceuticals & Research Limited and the driving force behind the company’s journey since its inception. A postgraduate in Chemistry from Agra University, he founded HAB Pharma with a clear vision—to build a pharmaceutical organization that delivers quality healthcare products while creating long-term value for customers, employees, partners, and society.
Over the years, Mr. Agarwal has played a hands-on role in virtually every aspect of the business. His deep understanding of the pharmaceutical industry, coupled with his entrepreneurial mindset, has helped shape HAB Pharma into a trusted and growing healthcare organization. While his leadership extends across all business functions, his core strengths lie in strategic procurement, supply chain management, and institutional sales—areas that have served as the backbone of the company’s growth and stability.
With decades of industry experience, Mr. Agarwal has built strong relationships across the pharmaceutical value chain, including suppliers, healthcare institutions, government organizations, and business partners. His ability to identify opportunities, negotiate effectively, and build lasting partnerships has enabled the company to strengthen its market presence while maintaining high standards of quality and reliability.
Known for his practical approach, sharp business acumen, and unwavering commitment to ethical business practices, Mr. Agarwal has always believed that sustainable growth comes from trust, consistency, and long-term relationships. Under his leadership, HAB Pharma has expanded its product portfolio, strengthened its manufacturing capabilities, and established a presence across domestic and international markets.
Despite the company’s growth, Mr. Agarwal continues to remain closely involved in key business decisions and strategic planning. His leadership style combines experience, humility, and a strong focus on execution, inspiring teams across the organization to strive for excellence every day.
His vision for HAB Pharmaceuticals remains simple yet ambitious—to build a globally respected pharmaceutical company that delivers high-quality, affordable healthcare solutions while upholding the highest standards of integrity, quality, and customer commitment.
Chairman and Managing Director
Director
Mr. Sanjiv Garg is the Director and Co-Founder of HAB Pharmaceuticals & Research Limited and has played a defining role in the company’s growth journey since its early years. A graduate in Chemistry from Mumbai University, Mr. Garg brings with him decades of rich industry experience, particularly in the areas of sales, distribution, and international business development. His strategic thinking, market understanding, and relationship-driven approach have been instrumental in establishing HAB Pharma as a trusted name across domestic and global markets.
Widely recognized for his exceptional strength in exports and international business expansion, Mr. Garg has been one of the key driving forces behind HAB Pharma’s growing global presence. Under his leadership, the company has successfully expanded its footprint across multiple international markets including the Middle East, Africa, Europe, Asia, and America. His deep understanding of export business dynamics, regulatory requirements, and international market behavior has helped HAB build long-standing partnerships and a strong reputation across global pharmaceutical markets.
From the very beginning, Mr. Garg has been closely involved in strengthening the company’s sales and distribution network and establishing efficient business processes that support sustainable growth. His practical business approach, strong execution capabilities, and focus on operational discipline have helped create a robust distribution ecosystem for the organization both in India and overseas.
Known for his calm leadership style, ethical business values, and commitment to excellence, Mr. Garg strongly believes in building relationships based on trust, consistency, and long-term collaboration. His ability to identify emerging opportunities and convert them into sustainable business growth has contributed significantly to HAB Pharma’s evolution into a globally expanding pharmaceutical company.
Over the years, he has remained deeply involved in strategic planning, export expansion, customer relationships, and market development initiatives. His passion for international business and dedication toward strengthening HAB’s global reach continue to inspire teams across the organization.
At HAB Pharmaceuticals, Mr. Garg continues to play a vital role in driving the company’s international growth strategy while reinforcing the organization’s core values of quality, reliability, and customer commitment. His vision and leadership remain central to HAB Pharma’s ambition of becoming a globally respected pharmaceutical brand with a strong presence across regulated and emerging markets.
Director
Director
Mr. Saurabh Agrawal is the Director of HAB Pharmaceuticals & Research Limited and represents the next phase of leadership shaping the company’s growth with speed, strategic clarity, and strong execution discipline. In his role, he leads new business development initiatives while overseeing the company’s marketing strategy and business planning, ensuring alignment between market opportunity, operational readiness, and long-term organisational goals.
With over 18 years of experience in the pharmaceutical industry, Mr. Agrawal has played a key role in building and sustaining partnerships across the value chain, including customers, suppliers, distributors, and regulatory stakeholders. He has been closely involved in the launch and scale-up of multiple high-quality products, contributing to both the company’s reputation and its commercial performance. His approach combines sharp market insight with structured planning, enabling the organisation to respond quickly to evolving market needs while maintaining quality and compliance benchmarks.
Widely regarded as a dynamic and progressive leader, Mr. Agrawal brings a strong execution mindset to the business. His core strengths lie in market analysis, contract negotiation, product development, customer relationship management, and operational optimization. He actively focuses on strengthening production efficiency, streamlining operations, and embedding robust systems that support sustainable scale-up. Known for his energetic leadership style and forward-looking thinking, he continuously works to reinforce the organization’s core values and institutional foundations.
Carrying forward the entrepreneurial legacy of HAB Pharma, Mr. Agrawal combines inherited business acumen with contemporary strategic thinking to give the company a competitive edge. His vision is firmly anchored in building a future-ready pharmaceutical organisation—one that delivers value to markets responsibly, adheres to the highest standards of quality, safety, and ethics, and steadily advances toward its ambition of becoming a globally respected pharmaceutical company.
Director
Director
Ms. Urvee Garg is a Director at HAB Pharmaceuticals & Research Limited and is actively involved in strengthening the organization’s regulatory, human resources, and international business functions. As a member of the next generation of leadership, she combines professional pharmaceutical knowledge with a modern management approach, helping the company build strong systems, enhance compliance standards, and support sustainable global growth.
A qualified pharmacist, Ms. Garg began her professional journey with reputed organizations such as Piramal Healthcare and AstraZeneca, where she gained valuable exposure to global pharmaceutical practices, regulatory frameworks, quality systems, and structured business processes. These experiences provided her with a strong foundation that she now leverages to support HAB Pharma’s evolving business and organizational objectives.
At HAB Pharmaceuticals, Ms. Garg plays a key role in overseeing regulatory affairs, export coordination, and human resource initiatives. She works closely with cross-functional teams to ensure compliance with regulatory requirements across various markets while supporting the company’s expanding international footprint. Her involvement in export operations helps facilitate smooth coordination between customers, regulatory agencies, and internal departments, ensuring timely execution and adherence to market-specific requirements.
In addition to her regulatory and export responsibilities, Ms. Garg is deeply involved in strengthening the organization’s people and culture initiatives. She actively contributes to talent development, employee engagement, organizational policies, and HR processes that support a high-performance and values-driven work environment. She believes that strong organizations are built on strong people and is committed to fostering a culture of collaboration, accountability, and continuous learning.
Known for her detail-oriented approach, strong interpersonal skills, and commitment to excellence, Ms. Garg brings a balanced perspective that combines compliance, people management, and business growth. Her ability to work across diverse functions enables her to contribute effectively to the company’s strategic objectives while ensuring operational discipline and organizational alignment.
As HAB Pharmaceuticals continues to expand its presence in global markets, Ms. Garg remains focused on strengthening regulatory excellence, developing talent, and supporting international growth initiatives. Through her leadership and dedication, she continues to contribute to HAB Pharma’s vision of becoming a globally respected pharmaceutical organization built on quality, integrity, and innovation.
Director
Director
Mrs. Vinita Krishnakumar Agarwal serves as a Director on the Board of HAB Pharmaceuticals & Research Ltd., where she contributes significantly to the Company’s strategic direction and long-term growth. With a strong academic foundation in Economics and a deep understanding of business dynamics, she plays an instrumental role in guiding the Company’s vision, governance, and sustainable development initiatives.
As a member of the Board, she provides valuable insights into strategic planning, policy formulation, and organizational decision-making. Her analytical approach and balanced perspective enable the Company to identify emerging opportunities, manage business risks effectively, and build resilient growth strategies in an evolving pharmaceutical landscape.
Mrs. Agarwal actively supports the leadership team in strengthening corporate governance practices and fostering a culture of accountability, innovation, and operational excellence. Her focus on sustainable value creation ensures that the Company’s growth remains aligned with the interests of its stakeholders, employees, customers, and business partners.
She holds a Master of Arts (M.A.) in Economics, and her academic expertise complements her strategic contributions to the Company’s continued success. Through her guidance and commitment, she continues to support HAB Pharmaceuticals & Research Ltd. in its mission to deliver high-quality pharmaceutical solutions while maintaining the highest standards of integrity, governance, and corporate responsibility.
Director
Director
Mrs. Renu Garg serves as a Director on the Board of HAB Pharmaceuticals & Research Ltd., contributing to the Company’s strategic leadership and long-term vision. With a strong academic background in Chemistry, she brings a scientific perspective that complements the Company’s commitment to quality, innovation, and excellence in the pharmaceutical industry.
As a member of the Board, Mrs. Garg plays a key role in supporting strategic planning, corporate governance, and policy formulation. Her balanced approach and thoughtful insights contribute to informed decision-making, enabling the Company to navigate evolving industry dynamics while maintaining a strong focus on sustainable growth and operational excellence.
She actively supports initiatives that strengthen organizational performance, promote ethical business practices, and reinforce the Company’s commitment to delivering safe, effective, and high-quality healthcare solutions. Her contributions help foster a culture of accountability, continuous improvement, and stakeholder value creation.
Mrs. Garg’s scientific foundation, combined with her strategic outlook, enables her to provide meaningful guidance to the Board as HAB Pharmaceuticals & Research Ltd. continues to expand its presence in domestic and international markets. Her commitment to the Company’s values and long-term objectives supports HAB Pharma’s mission of improving lives through trusted and affordable pharmaceutical products.
Director
Independent Director
Dr. Aditya Sureshchandra Agrawal serves as an Independent Director on the Board of HAB Pharmaceuticals & Research Ltd. He is a highly qualified medical professional with over 15 years of experience in respiratory medicine and is currently a Consultant Pulmonologist at Breach Candy Hospital and Bombay Hospital & Institute of Medical Sciences, Mumbai.
With extensive clinical expertise and a strong understanding of healthcare delivery, patient care, and medical ethics, Dr. Agrawal brings valuable insights to the Board. His experience in the healthcare sector, coupled with his knowledge of regulatory compliance and clinical governance, enables him to contribute effectively to the Company’s governance framework, risk oversight, and strategic decision-making.
As an Independent Director, Dr. Agrawal provides an objective perspective, upholds the highest standards of integrity and corporate governance, and supports the Company’s commitment to ethical, sustainable, and responsible growth.
Independent Director
Head of Sales
Mr. Madanan Raghavan Chulliparambil serves as an Independent Director on the Board of HAB Pharmaceuticals & Research Ltd., where he contributes to strengthening the company’s governance framework through independent oversight, objective guidance, and strategic counsel. His role is instrumental in promoting transparency, accountability, and sound corporate governance practices across the organization.
As an Independent Director, he provides an unbiased perspective on key strategic and operational matters, helping the Board make well – informed decisions that align with the company’s long term objectives and the interest of all stakeholders. His independent judgement enhances the effectiveness of Board deliberations and supports the development of balanced, sustainable business strategies.
Mr. Chulliparambil actively contributes to fostering a culture of ethical leadership, regulatory compliance, and responsible corporate governance. His guidance reinforces the company’s commitment to maintainig the highest standards of integrity, risk management and stakeholders confidence while navigating an evolving business environment.
Through his independent oversight and commitment to best governance practices, Mr. Chulliparambil continues to support HAB Pharmaceuticals & Research Ltd. in its pursuit of sustainable growth, operational excellence, and long-term value creation for shareholders, customers, employees, and the wider community.
Independent Director
CFO
Pankaj Agarwal is a distinguished finance executive and Chartered Accountant with over 15 years of leadership experience at the intersection of financial strategy, corporate governance, and business transformation. A first-attempt qualifier of the CA examinations conducted by the Institute of Chartered Accountants of India (ICAI) and a postgraduate from the prestigious SPJIMR, Mumbai, Pankaj brings to his role an uncommon blend of technical depth and strategic vision that sets him apart in the competitive landscape of pharmaceutical finance. In his capacity as Chief Financial Officer, he serves as a key architect of the organisation’s financial ecosystem — overseeing capital allocation, treasury and liquidity management, investor relations, regulatory compliance across Income Tax, GST, FEMA, and RBI frameworks, and the integrity of financial reporting at the board and audit committee level. Over the course of his career, which includes senior leadership roles at Innovcare Lifesciences and Max Hospital, he has demonstrated a consistent ability to drive value creation through disciplined financial planning, successful capital raises, ERP-led process transformation, and the institutionalisation of governance frameworks that inspire stakeholder confidence. A trusted advisor to promoters and management alike, Pankaj is recognised for his capacity to translate financial complexity into actionable business insight — bringing clarity, conviction, and commercial acumen to every boardroom conversation.
CFO
Executive Director
Mr. Sanjay Gaud serves as the Executive Director at HAB Pharmaceuticals & Research Limited and is one of the organization’s longest-serving leaders, having been associated with the company for over 18 years. His professional journey is closely intertwined with the growth and evolution of HAB Pharma, making him an integral part of the company’s success story. Through his dedication, commitment, and deep understanding of the business, he has played a significant role in strengthening the company’s presence in the institutional healthcare segment.
Over the years, Mr. Gaud has developed extensive expertise in institutional sales, government business, tender management, and customer relationship development. He has been instrumental in building and expanding HAB Pharma’s institutional business by successfully managing complex tender processes, developing strong relationships with government agencies, healthcare institutions, procurement bodies, and business partners, and ensuring consistent execution across diverse markets.
Having grown alongside the organization, Mr. Gaud possesses a unique understanding of HAB Pharma’s products, customers, and operational capabilities. His practical knowledge of institutional procurement systems and his ability to navigate evolving market requirements have helped the company secure and sustain key business opportunities across the healthcare sector. He has consistently focused on creating long-term value through disciplined execution, customer engagement, and a solution-oriented approach.
Known for his reliability, perseverance, and strong work ethic, Mr. Gaud has earned the trust and respect of colleagues, customers, and stakeholders alike. His leadership style is rooted in teamwork, accountability, and relationship building, and he actively contributes to developing a culture of commitment and performance within the organization.
As Executive Director, Mr. Gaud continues to lead HAB Pharma’s institutional sales and tender business while supporting the company’s broader commercial objectives. His deep industry experience, customer-centric approach, and unwavering commitment to the organization remain valuable assets as HAB Pharmaceuticals continues its journey of growth and expansion.
His story reflects the spirit of HAB Pharma itself—built on dedication, long-term relationships, and the belief that consistent effort and integrity create lasting success.
Executive Director
Plant Head Vasai
Mr. Bhupati Kumar Giri serves as the Plant Head at HAB Pharmaceuticals & Research Limited and is responsible for leading the company’s manufacturing operations, operational excellence initiatives, technology transfer programs, and capacity expansion projects. With a strong focus on quality, productivity, regulatory compliance, and continuous improvement, he plays a pivotal role in ensuring efficient, compliant, and sustainable pharmaceutical manufacturing operations across the organization.
With over 22 years of experience in the pharmaceutical industry, Mr. Giri brings extensive expertise in production management, plant operations, greenfield project execution, process validation, technology transfer, and regulatory compliance. Throughout his distinguished career, he has held leadership positions with leading pharmaceutical organizations including Ranbaxy Laboratories, Windlass Healthcare, Zim Laboratories, Troikaa Pharmaceuticals, Hasan Dermapharm Vietnam, and Pelltech Healthcare. His experience spans solid oral dosage forms, effervescent tablets, oral thin films, cephalosporin products, liquids, ointments, and advanced pharmaceutical manufacturing technologies.
Mr. Giri has successfully led large-scale manufacturing facilities, managed technology transfers of multiple products, executed qualification and validation programs, and driven operational excellence through Lean Manufacturing, Kaizen, 5S, and continuous improvement methodologies. He possesses deep expertise in process optimization, risk assessment, supply chain coordination, capacity enhancement, cost reduction initiatives, and implementation of global GMP requirements. His proven ability to align production efficiency with quality and compliance objectives has consistently delivered measurable improvements in productivity, operational reliability, and business performance.
A highly accomplished pharmaceutical leader, Mr. Giri has extensive experience in handling international regulatory inspections and audits, including US FDA, EU-GMP, UK MHRA, TGA, ANVISA, MCC, WHO-GMP, and various international health authorities. He has successfully led manufacturing teams through multiple global inspections and has been instrumental in establishing robust quality and compliance systems across manufacturing facilities. His international exposure also includes leading a greenfield pharmaceutical project in Vietnam, where he played a key role in facility design, qualification, validation, equipment procurement, and project execution.
Known for his strategic mindset, strong technical acumen, and people-centric leadership style, Mr. Giri is passionate about developing high-performing teams and fostering a culture of accountability, innovation, and operational excellence. His ability to combine technical expertise with business-focused decision-making enables him to drive sustainable growth while maintaining the highest standards of quality, safety, and regulatory compliance.
At HAB Pharmaceuticals, Mr. Giri is committed to strengthening manufacturing capabilities, enhancing operational efficiency, and building future-ready production systems that support the company’s long-term growth ambitions. Through his leadership and extensive industry experience, he continues to contribute significantly to HAB’s vision of becoming a globally respected pharmaceutical organization known for quality, reliability, and innovation.
Head of Sales
GM: Business Development
Mr. Girish Sharma is the General Manager – Business Development at HAB Pharmaceuticals & Research Limited, where he leads the company’s CMO/CDMO business initiatives, strategic partnerships, and customer engagement efforts. With over 11 years of experience in the pharmaceutical industry, he has built a strong track record in contract manufacturing, business expansion, commercial negotiations, and client relationship management.
In his role, Mr. Sharma is responsible for driving business growth through the acquisition and development of strategic partnerships across domestic and international markets. He works closely with customers and internal stakeholders to align commercial opportunities with operational capabilities, ensuring seamless execution from product concept to delivery. His expertise spans contract negotiations, product costing, portfolio expansion, marketing strategy, and cross-functional coordination, enabling the organization to deliver sustainable growth while maintaining high standards of quality and compliance.
Recognized for his customer-centric approach and strong commercial acumen, Mr. Sharma has successfully managed large business portfolios and cultivated long-term relationships with leading pharmaceutical companies. His strengths lie in identifying new market opportunities, developing value-driven business solutions, and fostering collaboration across production, quality, regulatory, supply chain, and commercial teams. His ability to balance strategic thinking with execution excellence has contributed significantly to business growth and operational efficiency throughout his career.
At HAB Pharmaceuticals, Mr. Sharma remains focused on expanding the company’s business footprint, strengthening customer partnerships, and supporting the organization’s vision of becoming a globally trusted pharmaceutical partner. Through his leadership, market insight, and commitment to excellence, he continues to play an important role in advancing HAB Pharma’s growth and long-term success.
GM: Business Development
GM Plat Operations
Mr. Sanjay Gupta is the General Manager – Plant Operations at HAB Pharmaceuticals & Research Limited, where he leads the company’s manufacturing operations with a focus on operational excellence, regulatory compliance, productivity enhancement, and sustainable growth. With over 19 years of experience in pharmaceutical manufacturing and plant management, he plays a critical role in ensuring efficient, quality-driven, and compliant operations across the organization.
An accomplished pharmaceutical operations leader, Mr. Gupta has extensive expertise in production management, cGMP compliance, quality systems, capacity planning, lean manufacturing, and cost optimization. Throughout his career, he has successfully led large-scale manufacturing facilities, implemented operational improvements, and managed greenfield pharmaceutical projects that significantly enhanced production capabilities and business performance.
Mr. Gupta is widely recognized for his strong leadership in regulatory compliance and audit readiness, having successfully managed inspections and audits from multiple international regulatory authorities. His expertise in quality management systems, operational risk management, process improvement, and digital transformation has helped organizations strengthen compliance standards while improving efficiency and productivity.
At HAB Pharmaceuticals, Mr. Gupta is focused on building world-class manufacturing capabilities through continuous improvement, technological advancement, and people development. His commitment to operational excellence, quality, safety, and regulatory integrity supports the company’s vision of delivering high-quality pharmaceutical products to global markets while maintaining the highest industry standards.
GM Plat Operations
Plant Head
Mr. Sunil Kumar Bhatt serves as the Plant Head at HAB Pharmaceuticals & Research Limited and is responsible for driving manufacturing excellence, operational efficiency, regulatory compliance, and continuous improvement across the company’s production facilities. With a strong focus on quality, productivity, and process optimization, he plays a critical role in ensuring that manufacturing operations consistently meet the highest standards of safety, compliance, and customer satisfaction.
With over 20 years of experience in the pharmaceutical industry, Mr. Bhatt brings extensive expertise in the manufacturing and packaging of a wide range of pharmaceutical dosage forms, including tablets, capsules, and liquid orals. Throughout his career, he has successfully managed large-scale production operations, technology transfers, capacity expansion projects, and cross-functional manufacturing teams. He has also been approved by multiple state regulatory authorities as a competent manufacturing professional for solid oral and liquid dosage forms, reflecting his deep technical knowledge and regulatory understanding.
Mr. Bhatt has significant experience in handling more than 100 tablet products and over 50 capsule formulations, including immediate-release, sustained-release, film-coated, sugar-coated, enteric-coated, dispersible, and pellet-based dosage forms. His expertise spans process validation, cleaning validation, quality management systems, investigation management, corrective and preventive actions (CAPA), and implementation of Good Manufacturing Practices (GMP) in line with national and international regulatory requirements. He has successfully supported and faced inspections from regulatory agencies and global customers, including WHO and international health authorities.
Known for his hands-on leadership style and strong operational discipline, Mr. Bhatt is passionate about building high-performing teams and fostering a culture of accountability, continuous learning, and operational excellence. He has consistently contributed to improving manufacturing efficiencies, reducing market complaints, optimizing resource utilization, and implementing automation-driven improvements that enhance productivity and product quality. His ability to align people, processes, and technology enables the organization to achieve sustainable growth while maintaining the highest standards of compliance and reliability.
At HAB Pharmaceuticals, Mr. Bhatt is committed to strengthening manufacturing capabilities, enhancing operational resilience, and supporting the company’s vision of becoming a globally trusted pharmaceutical organization. Through his deep industry knowledge, technical expertise, and dedication to quality, he continues to play a pivotal role in delivering safe, effective, and high-quality healthcare products to patients worldwide.
Plant Head
Plant Head Vasai
Mr. Bhupati Kumar Giri serves as the Plant Head at HAB Pharmaceuticals & Research Limited and is responsible for leading the company’s manufacturing operations, operational excellence initiatives, technology transfer programs, and capacity expansion projects. With a strong focus on quality, productivity, regulatory compliance, and continuous improvement, he plays a pivotal role in ensuring efficient, compliant, and sustainable pharmaceutical manufacturing operations across the organization.
With over 22 years of experience in the pharmaceutical industry, Mr. Giri brings extensive expertise in production management, plant operations, greenfield project execution, process validation, technology transfer, and regulatory compliance. Throughout his distinguished career, he has held leadership positions with leading pharmaceutical organizations including Ranbaxy Laboratories, Windlass Healthcare, Zim Laboratories, Troikaa Pharmaceuticals, Hasan Dermapharm Vietnam, and Pelltech Healthcare. His experience spans solid oral dosage forms, effervescent tablets, oral thin films, cephalosporin products, liquids, ointments, and advanced pharmaceutical manufacturing technologies.
Mr. Giri has successfully led large-scale manufacturing facilities, managed technology transfers of multiple products, executed qualification and validation programs, and driven operational excellence through Lean Manufacturing, Kaizen, 5S, and continuous improvement methodologies. He possesses deep expertise in process optimization, risk assessment, supply chain coordination, capacity enhancement, cost reduction initiatives, and implementation of global GMP requirements. His proven ability to align production efficiency with quality and compliance objectives has consistently delivered measurable improvements in productivity, operational reliability, and business performance.
A highly accomplished pharmaceutical leader, Mr. Giri has extensive experience in handling international regulatory inspections and audits, including US FDA, EU-GMP, UK MHRA, TGA, ANVISA, MCC, WHO-GMP, and various international health authorities. He has successfully led manufacturing teams through multiple global inspections and has been instrumental in establishing robust quality and compliance systems across manufacturing facilities. His international exposure also includes leading a greenfield pharmaceutical project in Vietnam, where he played a key role in facility design, qualification, validation, equipment procurement, and project execution.
Known for his strategic mindset, strong technical acumen, and people-centric leadership style, Mr. Giri is passionate about developing high-performing teams and fostering a culture of accountability, innovation, and operational excellence. His ability to combine technical expertise with business-focused decision-making enables him to drive sustainable growth while maintaining the highest standards of quality, safety, and regulatory compliance.
At HAB Pharmaceuticals, Mr. Giri is committed to strengthening manufacturing capabilities, enhancing operational efficiency, and building future-ready production systems that support the company’s long-term growth ambitions. Through his leadership and extensive industry experience, he continues to contribute significantly to HAB’s vision of becoming a globally respected pharmaceutical organization known for quality, reliability, and innovation.
Plant Head Vasai
Sr. Manager CQA
Mr. Rajesh Vinayak Kshirsagar serves as the Senior Manager – Corporate Quality Assurance at HAB Pharmaceuticals & Research Limited and is responsible for strengthening the organization’s quality systems, regulatory compliance framework, and continuous improvement initiatives across the pharmaceutical value chain. In his role, he leads corporate quality assurance activities, vendor qualification programs, audit management, quality governance, and compliance oversight, ensuring that all products and processes consistently meet global quality and regulatory standards.
With over 20 years of diverse experience spanning pharmaceuticals, healthcare products, cosmetics, fragrances, and international quality systems, Mr. Kshirsagar brings deep expertise in Corporate Quality Assurance (CQA), Quality Management Systems (QMS), regulatory compliance, vendor audits, quality investigations, and process excellence. Throughout his career, he has worked with renowned organizations including Cipla, Dr. Reddy’s Laboratories, Sandoz (Novartis), Ajmal Perfumes UAE, and leading pharmaceutical companies in India, gaining extensive exposure to both domestic and international regulatory environments.
Mr. Kshirsagar has successfully led internal, external, and vendor audits, managed CAPA programs, change controls, deviations, market complaints, recalls, risk assessments, and compliance initiatives in accordance with global standards such as ICH, GMP, ISO, and international regulatory requirements. His expertise extends to supplier qualification, contract manufacturing oversight, quality governance, training and competency development, root cause investigations, and implementation of robust quality systems that drive operational excellence and regulatory readiness. He is also highly experienced in supporting regulatory inspections, quality due diligence, and cross-functional quality improvement programs.
Recognized for his analytical approach and strong problem-solving capabilities, Mr. Kshirsagar combines technical expertise with strategic quality leadership. He is passionate about fostering a culture of quality, accountability, and continuous improvement, while enabling teams to achieve operational efficiency without compromising compliance. His extensive experience in quality control, quality assurance, laboratory systems, and corporate quality management allows him to effectively bridge technical operations with organizational quality objectives.
At HAB Pharmaceuticals, Mr. Kshirsagar plays a pivotal role in reinforcing the company’s quality culture and strengthening systems that support sustainable growth. His vision is centered on building a proactive quality organization that not only meets regulatory expectations but consistently exceeds customer requirements through excellence in compliance, risk management, and continuous improvement. Through his leadership, HAB continues to advance its commitment to delivering safe, effective, and high-quality pharmaceutical products to patients and healthcare partners worldwide.
Sr. Manager CQA
